These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14695729)

  • 1. Developmental regulation of codeine analgesia in the rat.
    Williams DG; Dickenson A; Fitzgerald M; Howard RF
    Anesthesiology; 2004 Jan; 100(1):92-7. PubMed ID: 14695729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precipitated withdrawal following codeine administration is dependent on CYP genotype.
    Chew M; White JM; Somogyi AA; Bochner F; Irvine RJ
    Eur J Pharmacol; 2001 Aug; 425(3):159-64. PubMed ID: 11513833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model.
    Cleary J; Mikus G; Somogyi A; Bochner F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1528-34. PubMed ID: 7996467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextromethorphan differentially affects opioid antinociception in rats.
    Chen SL; Huang EY; Chow LH; Tao PL
    Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain.
    Bardin L; Tarayre JP; Malfetes N; Koek W; Colpaert FC
    Pharmacology; 2003 Apr; 67(4):182-94. PubMed ID: 12595749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential behavioral effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation.
    Perrot S; Guilbaud G; Kayser V
    Anesthesiology; 2001 May; 94(5):870-5. PubMed ID: 11388540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response.
    McMillan DM; Tyndale RF
    Biochem Pharmacol; 2017 Dec; 145():158-168. PubMed ID: 28837793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotype.
    Mikus G; Trausch B; Rodewald C; Hofmann U; Richter K; Gramatté T; Eichelbaum M
    Clin Pharmacol Ther; 1997 Apr; 61(4):459-66. PubMed ID: 9129563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive/anti-edema effects of liposomal morphine during acute inflammation of the rat paw.
    Planas E; Sánchez S; Rodriguez L; Pol O; Puig MM
    Pharmacology; 2000 Apr; 60(3):121-7. PubMed ID: 10754448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
    Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.
    Doyle HH; Murphy AZ
    Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats.
    Zissen MH; Zhang G; McKelvy A; Propst JT; Kendig JJ; Sweitzer SM
    Neuroscience; 2007 Jan; 144(1):247-62. PubMed ID: 17055659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
    Dong Z; Han H; Cao J; Xu L
    Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
    Nozaki-Taguchi N; Yaksh TL
    Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation.
    Johnson JL; Rolan PE; Johnson ME; Bobrovskaya L; Williams DB; Johnson K; Tuke J; Hutchinson MR
    Transl Psychiatry; 2014 Nov; 4(11):e482. PubMed ID: 25386959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of sex differences in morphine analgesia elicited from the ventrolateral periaqueductal gray in rats by neonatal hormone manipulations.
    Krzanowska EK; Ogawa S; Pfaff DW; Bodnar RJ
    Brain Res; 2002 Mar; 929(1):1-9. PubMed ID: 11852025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
    Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
    Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.